Fuse Medical Osake

Fuse Medical EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Fuse Medical (FZMD) 12.8.2026 päivämäärällä on 383 783,00 USD. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli 721 412,00 USD — muutos −46,80 % (matalampi).

EBITDA

383 783,00USD

YoY

−46,80%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Fuse Medical on 2026 383 783,00 USD. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Fuse Medical oli 2025 721 412,00 USD. Se laskee −46,80% matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Fuse Medical Osakeanalyysi

Mitä Fuse Medical tekee? Fuse Medical Inc. is a US-based company specializing in the distribution of orthopedic implants and blood circulation products. Founded in 2014, the company is headquartered in Richardson, Texas. The business model of Fuse Medical is based on the distribution of orthopedic implants, consumables, and instruments to medical practices, hospitals, and surgical facilities. The company works closely with leading manufacturers to offer its customers a wide range of high-quality products. Fuse Medical's product range includes primary and revision implants for various areas such as hips, knees, shoulders, and the spine. In addition, Fuse Medical also offers a wide range of instruments to meet the needs of its customers. These products are supplied by a variety of manufacturers from around the world, allowing Fuse Medical to meet the needs of its customers. In recent years, Fuse Medical has also focused on the distribution of blood circulation products, including non-invasive devices to improve circulation and devices for the treatment of wound healing disorders. These products contribute to improving the quality of life for patients and are an important part of the company's business model. Fuse Medical has experienced good development in recent years and has successfully established itself in the market for orthopedic implants. The company is constantly working to expand its product range and support its customers around the world. This includes continuous training and education of staff to continuously improve the quality of products and customer service. In addition to the distribution of implants and medical devices, Fuse Medical also offers a wide range of services to its customers. This includes fast delivery directly to facilities, inventory management, support for storage, distribution, and maintenance of medical equipment, as well as training for medical personnel. Fuse Medical aims to offer high-quality products and services that meet customer needs and contribute to improving patient care. The company is committed to continuously developing new products through innovation and research that meet the needs of its customers and the latest industry requirements. In summary, Fuse Medical is a successful company specializing in the distribution of orthopedic implants and blood circulation products. The company offers a wide range of products and services and works closely with its customers and manufacturers to ensure the highest quality. Fuse Medical will continue to strive to provide its customers with the best products and services and establish itself as a leading company in the industry. Fuse Medical specializes in the distribution of orthopedic implants and blood circulation products. Fuse Medical on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Fuse Medical osakkeesta

Yhtiön Fuse Medical EBITDA (Tulos ennen korkoja, veroja ja poistoja) on 383 783,00 USD vuonna 2026.

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Fuse Medical muuttui arvosta 721 412,00 USD arvoon 383 783,00 USD, mikä edustaa −46,80 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) Fuse Medical:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n USD on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n Fuse Medical historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API

Tuloslaskelma — Fuse Medical

Kaikki tunnusluvut — Fuse Medical